Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Ipratropium-Albuterol Treatment Report
What is Ipratropium-Albuterol?

Ipratropium and albuterol (salbutamol) is a bronchodilator that combine ipratropium bromide and albuterol sulfate (salbutamol) and is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is available in a nebulizer solution and as an inhalant.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Breathing difficulty 3 0
Asthma 2 0
General health 2 1
resolving mucus and widening for breathing 1 0
disease-related symptoms 1 0
problems breathing (asthma issues at some level) 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

Top 10 dosages based on patients currently taking Ipratropium-Albuterol. See all 12 dosages

  2 90mcg-18mcg/inh as needed 90mcg-18mcg/inh as needed daily 1 other daily 1.5 mcg daily 3 other daily 4 other daily 5 mg daily 4 x 2.5 mg-0.5 mg/3 mL daily 12 mg daily 3 x 90 mcg-18 mcg/inh daily 29400 mcg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Currently Taking Ipratropium-Albuterol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
4
0
1
3

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 100%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 24, 2009.